Involvement of 5-hydroxytryptamine neuronal system in Δ9-tetrahydrocannabinol-induced impairment of spatial memory

Nobuaki Egashira, Kenichi Mishima, Shutaro Katsurabayashi, Tomohiro Yoshitake, Yoshiaki Matsumoto, Junichi Ishida, Masatoshi Yamaguchi, Katsunori Iwasaki, Michihiro Fujiwara

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The present study investigated the involvement of the serotonin (5-hydroxytryptamine, 5-HT) neuronal system in the Δ9-tetrahydrocannabinol-induced impairment of spatial memory in the eight-arm radial maze in rats. Δ9-Tetrahydrocannabinol (6 mg/kg, i.p.), which impairs spatial memory, significantly increased the 5-HT content in the ventral hippocampus. A microdialysis study showed that Δ9-tetrahydrocannabinol (6 mg/kg, i.p.) decreased 5-HT release in the ventral hippocampus. The 5-HT precursor, 5-hydroxy-L-tryptophan (5-HTP; 50 mg/kg, i.p.), the 5-HT re-uptake inhibitor, clomipramine (0.01 and 0.1 mg/kg, i.p.), the 5-HT receptor agonist, 5-methoxy-N, N-dimethyltryptamine (5-MeODMT; 0.01 and 0.03 mg/kg, i.p.), and the 5-HT2 receptor agonist, 1-(2,5-dimethoxy 4-iodophenyl)-2-amino propane (DOI; 10 μg/kg, i.p.), significantly attenuated the Δ9-tetrahydrocannabinol-induced impairment of spatial memory. These results suggest that the 5-HT neuronal system may be involved in the Δ9-tetrahydrocannabinol-induced impairment of spatial memory.

Original languageEnglish
Pages (from-to)221-229
Number of pages9
JournalEuropean Journal of Pharmacology
Volume445
Issue number3
DOIs
Publication statusPublished - Jun 12 2002
Externally publishedYes

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this